Influenza vaccination coverage at community pharmacies: Positioning, needs, expectations and involvement of community pharmacists in the Franche-Comté region.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
May 2021
Historique:
received: 28 09 2019
accepted: 08 10 2020
pubmed: 20 10 2020
medline: 27 8 2021
entrez: 19 10 2020
Statut: ppublish

Résumé

Influenza vaccination coverage currently remains below the 75% recommended threshold by the World Health Organization. To correct this situation, experiments have been successively carried out in France to enable community pharmacists to vaccinate at-risk populations. In this context, a study was conducted with pharmacists from the French Franche-Comté region to evaluate their positioning, needs and expectations regarding influenza vaccination at community pharmacies. A survey was created and sent to licensed pharmacists in March of 2018. This consisted of 4 parts: characteristics of the community pharmacy; positioning of the pharmacist regarding vaccinations carried out at the pharmacy; training needs and expectations; and willingness to implement vaccinations. The participation rate in this survey was 32% (137/427). More than 90% of the pharmacists agreed that community pharmacies' assets were adequate for the implementation of these vaccinations (accessibility and availability), although 52% considered this complicated. Their main fears were reluctance from patients and conflicts of interest with other health professionals authorized to vaccinate (58%). The needs and expectations regarding pharmacy student training were essential for 94% of them as well as continuous training of practicing pharmacists (96%). The willingness of pharmacists to vaccinate stemmed from the fact that influenza vaccination coverage would increase for at-risk subjects (36%). This survey allowed us to assess the favorable positioning and the real interest of pharmacists from Franche-Comté regarding the influenza vaccination done at community pharmacies, given the proviso that they were given relevant training and allocated adequate resources.

Identifiants

pubmed: 33075402
pii: S0399-077X(20)30739-3
doi: 10.1016/j.medmal.2020.10.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-289

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

M Kroemer (M)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR Inserm1098, interactions hôte-greffon-tumeur - ingénierie cellulaire et génique, université Bourgogne-Franche-Comté, Besançon, France.

A L Clairet (AL)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR Inserm1098, interactions hôte-greffon-tumeur - ingénierie cellulaire et génique, université Bourgogne-Franche-Comté, Besançon, France.

K Kabiche (K)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France.

A Bendjama (A)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France.

X Bertrand (X)

Service d'hygiène hospitalière, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR CNRS 6249, laboratoire chrono-environnement, université de Franche-Comté, Besançon, France.

S Limat (S)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR Inserm1098, interactions hôte-greffon-tumeur - ingénierie cellulaire et génique, université Bourgogne-Franche-Comté, Besançon, France.

V Nerich (V)

Pôle pharmacie, CHU de Besançon, 3, boulevard Alexandre-Fleming, 25030 Besançon cedex, France; UMR Inserm1098, interactions hôte-greffon-tumeur - ingénierie cellulaire et génique, université Bourgogne-Franche-Comté, Besançon, France. Electronic address: v1nerich@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH